Purexa™ PrA Mike Binder Purexa™ PrA Mike Binder

High throughput purification of monoclonal recombinant antibodies using a Protein-A coated membrane plate system

Purilogics’ Jinxiang Zhou recently co-authored an article alongside Camila Leal-Lopes, Sara D’Angelo, Andre A.R. Teixeira, Andrew R.M Bradbury, Fortunato Ferrara, and M. Frank Erasmus – the Head of Bioinformatics at Specifica, Inc. We are excited to announce that this article has been published in the New Biotechnology Journal: High throughput purification of monoclonal recombinant antibodies using a Protein-A coated membrane plate system.

Read More
Purexa™ PrA jeremy hogenbaum Purexa™ PrA jeremy hogenbaum

Purilogics to Present at Antibody Engineering & Therapeutics Conference

We’re excited to attend the Antibody Engineering & Therapeutics Conference in San Diego, CA from December 13th to 17th! Hosted by the Antibody Society, which is dedicated to the promotion of antibody research and development, this conference showcases the latest antibody technologies and science to accelerate next generation antibodies towards commercial success.

Read More
Purexa™ PrA Purilogics contributor Purexa™ PrA Purilogics contributor

Purexa™ PrA mini - Fast Antibody Purification within 1 Minute

Purexa™ PrA mini is designed for rapid processing of small quantity of antibodies, especially at low titers. During elution, the first 0.5 mL was discarded. As is shown in the fitures, a majority of the antibody was eluted in the second 0.5 mL elution fraction, which had a concentration of 3.3 mg/mL and was corresponding to a recovery of 78%.

Read More